Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
2,021,286
-
Share change
-
+567,571
-
Total reported value
-
$3,851,000
-
Price per share
-
$1.91
-
Number of holders
-
16
-
Value change
-
+$1,491,357
-
Number of buys
-
10
-
Number of sells
-
3
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q3 2017
As of 30 Sep 2017,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,021,286 shares.
The largest 10 holders included
ASCEND CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, SPHERA FUNDS MANAGEMENT LTD., Park West Asset Management LLC, SHEPHERD KAPLAN KROCHUK, LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
16
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.